Product Information
ATOVAQUONE 750 MG/5 ML SUSP is a generic product labeled by Amneal Pharmaceuticals LLC, priced at $0.7668 per ML under NDC 65162069388. Its NADAC has been published 642 times since Jun 18, 2014.
FDA first approved this application on Mar 18, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
750 mg/5mL
Manufacturer
Amneal Pharmaceuticals LLCNDC
65162069388
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ATOVAQUONEApproval Type
Generic (ANDA)
FDA Application
ANDA202960FDA Approved
3/18/2014
TE Code
AB
On Market Since
2/9/2011
Pharmacological Classes
Price Statistics
The NADAC for ATOVAQUONE 750 MG/5 ML SUSP has been published 642 times since Jun 18, 2014, and over the history we have for it it has declined 83.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7668 per ML |
|---|---|
| All-time high | $4.5160 (Jul 16, 2014) |
| All-time low | $0.6842 (Jul 22, 2026) |
| 52-week high | $0.8766 |
| 52-week low | $0.6842 |
| Median price | $1.6286 |
| Average price | $2.0014 |
| Largest weekly change | +55.5% (Jan 20, 2021) |
| Weeks tracked | 642 |
| Tracking since | Jun 18, 2014 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ATOVAQUONE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antimalarial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ATOVAQUONE 750 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for ATOVAQUONE 750 MG/5 ML SUSP, manufactured by Amneal Pharmaceuticals LLC, is $0.7668 per ML (NDC 65162069388), effective Sep 30, 2026.
How has the price of ATOVAQUONE 750 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for ATOVAQUONE 750 MG/5 ML SUSP has declined 83.0%. It has been tracked across 642 weekly CMS publications since Jun 18, 2014.
What are the highest and lowest recorded NADAC prices for ATOVAQUONE 750 MG/5 ML SUSP?
Since Jun 18, 2014, the NADAC for ATOVAQUONE 750 MG/5 ML SUSP has ranged from a low of $0.6842 (Jul 22, 2026) to a high of $4.5160 (Jul 16, 2014), with a median of $1.6286 per ML.
Are there cheaper alternatives to ATOVAQUONE 750 MG/5 ML SUSP?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ATOVAQUONE 750 MG/5 ML SUSP, is $0.7185 per ML — about 6% below ATOVAQUONE 750 MG/5 ML SUSP.
Who manufactures ATOVAQUONE 750 MG/5 ML SUSP?
ATOVAQUONE 750 MG/5 ML SUSP (NDC 65162069388) is labeled by Amneal Pharmaceuticals LLC, and CMS classifies it as a generic product.